S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
4 stocks benefitting from NVIDIA's explosive growth
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Analysts boosted Snowflake stock, big firms are buying now
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Is CRISPR Therapeutics the NVIDIA of gene editing?
First it was Tyson stock, now this food company is set to rally
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
6 reasons to buy Teva Pharmaceuticals stock sooner than later
Block's multiple ecosystems drive shares higher on 2024 outlook
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
4 stocks benefitting from NVIDIA's explosive growth
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Analysts boosted Snowflake stock, big firms are buying now
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Is CRISPR Therapeutics the NVIDIA of gene editing?
First it was Tyson stock, now this food company is set to rally
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
6 reasons to buy Teva Pharmaceuticals stock sooner than later
Block's multiple ecosystems drive shares higher on 2024 outlook
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
4 stocks benefitting from NVIDIA's explosive growth
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Analysts boosted Snowflake stock, big firms are buying now
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Is CRISPR Therapeutics the NVIDIA of gene editing?
First it was Tyson stock, now this food company is set to rally
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
6 reasons to buy Teva Pharmaceuticals stock sooner than later
Block's multiple ecosystems drive shares higher on 2024 outlook
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
4 stocks benefitting from NVIDIA's explosive growth
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Analysts boosted Snowflake stock, big firms are buying now
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Is CRISPR Therapeutics the NVIDIA of gene editing?
First it was Tyson stock, now this food company is set to rally
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
6 reasons to buy Teva Pharmaceuticals stock sooner than later
Block's multiple ecosystems drive shares higher on 2024 outlook

Cocrystal Pharma (COCP) Institutional Ownership

$1.44
-0.01 (-0.69%)
(As of 02/23/2024 08:52 PM ET)

Institutional Ownership Changes (13F Filings) for Cocrystal Pharma (NASDAQ:COCP)

Current
Institutional Ownership
Percentage
13.43%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$64,023.72
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$705,530.62
Get COCP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cocrystal Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

COCP Institutional Buying and Selling by Quarter


Cocrystal Pharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/11/2023Renaissance Technologies LLC124,528$0.30M0.0%+3.9%1.224%
5/16/2023Susquehanna International Group LLP20,728$41K0.0%N/A0.204%
5/16/2023Sabby Management LLC66,172$0.13M0.1%-84.3%0.650%
5/12/2023Renaissance Technologies LLC119,828$0.24M0.0%+5.1%1.178%
2/15/2023Morgan Stanley44,694$87K0.0%-91.7%0.550%
2/13/2023Renaissance Technologies LLC114,028$0.22M0.0%-92.9%1.404%
2/13/2023Geode Capital Management LLC69,534$0.13M0.0%-91.4%0.856%
2/6/2023Parallel Advisors LLC15,228$30K0.0%-91.7%0.188%
11/14/2022Renaissance Technologies LLC1,604,425$0.47M0.0%-5.7%19.761%
5/13/2022Renaissance Technologies LLC1,704,328$0.94M0.0%-10.4%1.749%
1/20/2022Parallel Advisors LLC182,708$0.12M0.0%-50.3%0.187%
11/15/2021Mariner LLC300,055$0.32M0.0%+50.0%0.308%
11/15/2021HighTower Advisors LLC63,001$66K0.0%-30.8%0.065%
11/12/2021Renaissance Technologies LLC2,026,766$2.13M0.0%-21.9%2.079%
11/9/2021Barclays PLC26,665$28K0.0%+248.5%0.027%
11/9/2021BlackRock Inc.1,113,765$1.17M0.0%-2.1%1.143%
11/2/2021Raymond James Financial Services Advisors Inc.24,243$25K0.0%+108.7%0.025%
9/17/2021Virtu Financial LLC116,625$0.15M0.0%+50.8%0.120%
8/24/2021Mariner LLC200,055$0.25M0.0%N/A0.205%
8/16/2021Squarepoint Ops LLC193,666$0.24M0.0%+323.5%0.199%
8/16/2021Alyeska Investment Group L.P.2,750,100$3.44M0.0%N/A2.822%
8/16/2021Charles Schwab Investment Management Inc.39,234$50K0.0%N/A0.040%
8/16/2021State Street Corp274,427$0.34M0.0%N/A0.282%
8/16/2021Sabby Management LLC6,110,657$7.64M1.1%N/A6.269%
8/16/2021Goldman Sachs Group Inc.138,168$0.17M0.0%+62.1%0.142%
8/13/2021Renaissance Technologies LLC2,593,933$3.24M0.0%-39.0%2.661%
8/13/2021Northern Trust Corp143,474$0.18M0.0%+64.7%0.147%
8/13/2021Altium Capital Management LP776,000$0.97M0.2%N/A0.796%
8/13/2021LPL Financial LLC153,500$0.19M0.0%+10.4%0.157%
8/13/2021Geode Capital Management LLC558,332$0.70M0.0%+61.4%0.573%
8/13/2021Vanguard Group Inc.3,103,035$3.88M0.0%+58.5%3.184%
8/12/2021Dimensional Fund Advisors LP140,447$0.18M0.0%-26.3%0.144%
8/6/2021HighTower Advisors LLC91,001$0.11M0.0%+152.8%0.093%
5/19/2021Virtu Financial LLC77,322$0.11M0.0%+124.8%0.079%
5/19/2021Squarepoint Ops LLC45,733$64K0.0%N/A0.047%
5/17/2021Goldman Sachs Group Inc.85,240$0.12M0.0%+164.1%0.119%
5/13/2021Renaissance Technologies LLC4,254,880$5.91M0.0%+7.7%5.953%
5/12/2021Geode Capital Management LLC345,893$0.48M0.0%+4.3%0.484%
5/10/2021GSA Capital Partners LLP43,225$60K0.0%N/A0.060%
4/23/2021Parallel Advisors LLC193,708$0.27M0.0%-4.2%0.271%
2/24/2021Virtu Financial LLC34,394$47K0.0%-62.5%0.050%
2/10/2021Renaissance Technologies LLC3,949,980$5.37M0.0%+3.3%5.761%
2/10/2021Brighton Jones LLC36,000$49K0.0%+100.0%0.053%
2/10/2021HighTower Advisors LLC31,100$42K0.0%N/A0.045%
2/9/2021Bank of New York Mellon Corp49,346$67K0.0%N/A0.072%
2/5/2021BlackRock Inc.1,106,970$1.51M0.0%N/A1.615%
2/2/2021Parallel Advisors LLC202,208$0.28M0.0%+57.3%0.295%
12/11/2020Virtu Financial LLC91,684$85K0.0%N/A0.134%
11/17/2020Jane Street Group LLC41,062$38K0.0%N/A0.079%
11/16/2020Point72 Asset Management L.P.2,857,143$2.66M0.0%N/A5.480%
8/11/2020Brighton Jones LLC18,000$27K0.0%N/A0.035%
7/31/2020UBS Group AG17,337$26K0.0%+54.8%0.033%
6/16/2020Royal Bank of Canada178,373$0.13M0.0%+140,351.2%0.342%
5/15/2020Sabby Management LLC392,206$0.28M0.1%N/A0.752%
5/11/2020Acadian Asset Management LLC187,425$0.13M0.0%+1,354.9%0.359%
4/27/2020Parallel Advisors LLC128,563$91K0.0%+161.6%0.247%
2/13/2020Renaissance Technologies LLC129,274$64K0.0%+1,128.8%0.368%
(Data available from 1/1/2016 forward)













COCP Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of COCP shares?

During the previous two years, the following institutional investors and hedge funds held shares of Cocrystal Pharma shares: Renaissance Technologies LLC ($0.30M), Geode Capital Management LLC ($0.13M), Sabby Management LLC ($0.13M), Morgan Stanley ($87K), and Susquehanna International Group LLP ($41K), Parallel Advisors LLC ($30K).Learn more on COCP's institutional investors.

What percentage of Cocrystal Pharma stock is owned by institutional investors?

13.43% of Cocrystal Pharma stock is owned by institutional investors. Learn more on COCP's institutional investor holdings.

Which institutional investors have been buying Cocrystal Pharma stock?

The following institutional investors have purchased Cocrystal Pharma stock in the last 24 months: Susquehanna International Group LLP ($20.73K), and Renaissance Technologies LLC ($10.50K).

How much institutional buying is happening at Cocrystal Pharma?

Institutional investors have bought a total of 31,228 shares in the last 24 months. This purchase volume represents approximately $64.02K in transactions.

Which Cocrystal Pharma major shareholders have been selling company stock?

The following institutional investors have sold Cocrystal Pharma stock in the last 24 months: Renaissance Technologies LLC ($1.79M), Geode Capital Management LLC ($0.74M), Morgan Stanley ($0.49M), Sabby Management LLC ($0.35M), and Parallel Advisors LLC ($0.17M).

How much institutional selling is happening at Cocrystal Pharma?

Institutional investors have sold a total of 3,540,296 shares in the last 24 months. This volume of shares sold represents approximately $7.99M in transactions.


This page (NASDAQ:COCP) was last updated on 2/26/2024 by MarketBeat.com Staff